Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique

被引：0
|
作者：
Bonny Parkinson
Sallie-Anne Pearson
Rosalie Viney
机构：
[1] University of Technology,Centre for Health Economics Research and Evaluation (CHERE)
[2] Sydney,Pharmacoepidemiology and Pharmaceutical Policy Research Group, Faculty of Pharmacy
[3] The University of Sydney,undefined
来源：
The European Journal of Health Economics | 2014年 / 15卷
关键词：
Economics; Cost-utility analysis; Cost-effectiveness analysis; Breast neoplasms; Metastatic; Trastuzumab; I18; D61;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 112
页数：19
相关论文
共 50 条
  • [1] Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique
    Parkinson, Bonny
    Pearson, Sallie-Anne
    Viney, Rosalie
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (01) : 93 - 112
  • [2] Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
    Jeyakumar, Alwin
    Younis, Tallal
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [3] Looking for Her (2+): A systematic review of the economic evaluations of Trastuzumab in early stage HER 2 positive breast cancer
    Petrou, Panagiotis
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (02) : 115 - 125
  • [4] A Review of Trastuzumab-Based Therapy in Patients with HER2-positive Metastatic Breast Cancer
    Church, David N.
    Price, Chris G. A.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 557 - 570
  • [5] The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review
    Tokuda, Yutaka
    Suzuki, Yasuhiro
    Saito, Yuki
    Umemura, Shinobu
    BREAST CANCER, 2009, 16 (04) : 295 - 300
  • [6] The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review
    Yutaka Tokuda
    Yasuhiro Suzuki
    Yuki Saito
    Shinobu Umemura
    Breast Cancer, 2009, 16 : 295 - 300
  • [7] Trastuzumab beyond progression in HER2-positive metastatic breast cancer
    Al-Naqqash, Manwar
    Jasim Al-Serarati, Waleed
    Farooq Kareem, Tara
    BREAST JOURNAL, 2021, 27 (03) : 297 - 299
  • [8] Role of trastuzumab in the management of HER2-positive metastatic breast cancer
    Milani, Andrea
    Montemurro, Filippo
    Gioeni, Luisa
    Aglietta, Massimo
    Valabrega, Giorgio
    BREAST CANCER-TARGETS AND THERAPY, 2010, 2 : 93 - 109
  • [9] Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer
    Andrew D. Seidman
    Larry Norton
    Current Oncology Reports, 2005, 7 (1) : 9 - 11
  • [10] Systemic treatment of HER2-positive metastatic breast cancer: A systematic review
    Wilcken, Nicholas
    Zdenkowski, Nicholas
    White, Michelle
    Snyder, Ray
    Pittman, Ken
    Mainwaring, Paul
    Green, Michael
    Francis, Prudence
    De Boer, Richard
    Colosimo, Maree
    Chua, Sue
    Chirgwin, Jacquie
    Beith, Jane
    Bell, Richard
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 1 - 14
12345